CORDIS
EU research results

CORDIS

English EN

DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE

Project information

Grant agreement ID: 951668

Status

Ongoing project

  • Start date

    1 June 2020

  • End date

    31 May 2022

Funded under:

H2020-EU.1.4.1.1.

  • Overall budget:

    € 1 879 216,25

  • EU contribution

    € 1 879 216,25

Coordinated by:

EUROPEAN VACCINE INITIATIVE EWIV

Germany

Objective

TRANSVAC-DS project further builds on the outstanding success of EC-funded projects:TRANSVAC1 and TRANSVAC2 and proposes the establishment of a truly sustainable European vaccine infrastructure, which will build upon the lessons learned, activities and achievements of the TRANSVAC1/2 projects.
Two infrastructure projects -TRANSVAC1 and TRANSVAC2- have been funded by the European Commission which -through the provision of state-of-the-art scientific-technical vaccine development services, technical training, and innovative vaccine research and development- have provided very significant support to European vaccine researchers and developers. Support has been, and is being provided to the development of human and veterinary prophylactic and therapeutic vaccines.
The twenty-five partners in the TRANSVAC-DS consortium that will contribute to the outcome of the project represent ten EU Member States and Associated Countries and include leading organisations from the European vaccine R&D field.
The main output of TRANSVAC-DS will be a conceptual design report that will describe in detail the maturity of the concept and be the basis for the establishment of a permanent and sustainable vaccine infrastructure of direct relevance to and benefit for Europe and further afield. As part of the design report, a five-year business plan will be delivered together with an implementation plan that will guide the further establishment of a sustainable European vaccine infrastructure.

Coordinator

EUROPEAN VACCINE INITIATIVE EWIV

Address

Vossstrasse 2 Geb 4040
69115 Heidelberg

Germany

Activity type

Research Organisations

EU Contribution

€ 989 025

Participants (24)

BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE

France

EU Contribution

€ 74 607,50

STICHTING BIOMEDICAL PRIMATE RESEARCH CENTER

Netherlands

EU Contribution

€ 52 206,25

ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK

France

EU Contribution

€ 33 750

EATRIS ERIC

Netherlands

EU Contribution

€ 39 375

FLANDERS VACCINE

Belgium

EU Contribution

€ 42 668,75

FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.

Germany

EU Contribution

€ 40 807,50

GENIBET - BIOPHARMACEUTICALS SA

Portugal

EU Contribution

€ 11 875

HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH

Germany

EU Contribution

€ 52 500

COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES

France

EU Contribution

€ 41 110

FUNDACIO MAS BADIA

Spain

EU Contribution

€ 26 202,50

INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT

France

EU Contribution

€ 34 141,25

MINISTERIE VAN VOLKSGEZONDHEID, WELZIJN EN SPORT

Netherlands

EU Contribution

€ 35 125

INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA

Portugal

EU Contribution

€ 22 875

INSTITUTO DE SALUD CARLOS III

Spain

EU Contribution

€ 24 715

INSTRUCT-ERIC

United Kingdom

EU Contribution

€ 35 000

ACADEMISCH ZIEKENHUIS LEIDEN

Netherlands

EU Contribution

€ 46 615

LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER

United Kingdom

EU Contribution

€ 20 921,25

MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY

United Kingdom

EU Contribution

€ 61 821,25

SCLAVO VACCINES ASSOCIATION

Italy

EU Contribution

€ 54 375

SCIENSANO

Belgium

EU Contribution

€ 32 500

STATENS SERUM INSTITUT

Denmark

EU Contribution

€ 16 625

UNIVERSITA DEGLI STUDI DI SIENA

Italy

EU Contribution

€ 30 750

VACCINE FORMULATION INSTITUTE(CH)LTD

Switzerland

EU Contribution

€ 28 750

STICHTING WAGENINGEN RESEARCH

Netherlands

EU Contribution

€ 30 875

Project information

Grant agreement ID: 951668

Status

Ongoing project

  • Start date

    1 June 2020

  • End date

    31 May 2022

Funded under:

H2020-EU.1.4.1.1.

  • Overall budget:

    € 1 879 216,25

  • EU contribution

    € 1 879 216,25

Coordinated by:

EUROPEAN VACCINE INITIATIVE EWIV

Germany